Australian Capital Territory Numbered Regulations

[Index] [Table] [Search] [Search this Regulation] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

MEDICINES, POISONS AND THERAPEUTIC GOODS AMENDMENT REGULATION 2019 (NO 1) (NO 23 OF 2019) - REG 25

Section 593

substitute

593     CHO decisions on applications to prescribe appendix D medicines

    (1)     The chief health officer must approve, or refuse to approve, an application by a prescriber under section 592 for approval to prescribe an appendix D medicine.

    (2)     An approval under subsection (1) to prescribe an appendix D medicine is subject to the following conditions:

        (a)     if the medicine is an ACT listed appendix D medicine—that the prescriber complies with any conditions in schedule 3, part 3.2, column 4 in relation to the medicine;

        (b)     any other condition included in the approval by the chief health officer.

Example—par (a)

If sch 3, pt 3.2, col 4 includes a condition requiring a prescriber to advise a woman of child-bearing age to avoid becoming pregnant during or for a certain period after the completion of treatment, the prescriber is authorised to prescribe the medicine only if the prescriber gives the patient the advice.

    (3)     For this section, the chief health officer—

        (a)     must have regard to the specialist area (if any) in which the prescriber practises and the requirements (if any) stated in the medicines and poisons standard, appendix D for the medicine to which the application relates; and

        (b)     may have regard to anything else the chief health officer considers appropriate.

    (4)     The chief health officer must send the prescriber written notice of the chief health officer's decision not later than 7 days after the day the decision is made.



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback